Private Capital Group, LLC Longeveron Inc. Transaction History

Private Capital Group, LLC

  • $133 Million
  • Q2 2022

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Jan 24, 2022
SELL
$2.92 - $42.3 $35,040 - $507,599
-12,000 Closed
0 $0
Q3 2021

Oct 13, 2021
BUY
$3.4 - $8.3 $23,800 - $58,100
7,000 Added 140.0%
12,000 $42,000
Q1 2021

Apr 12, 2021
BUY
$5.66 - $8.45 $28,300 - $42,250
5,000 New
5,000 $33,000

Others Institutions Holding LGVN

# of Institutions
2
Shares Held
1.18K
Call Options Held
0
Put Options Held
0
View Full List

About Longeveron Inc.

LGVN Quotes by TradingView
  • Ticker LGVN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 5,925,940
  • Market Cap $11.2M
  • Description
  • Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions. The company's lead investigational product is the LOMECEL-B, a cell-based therapy product that is derived from culture-expanded medicinal signaling cells that are sourced from bone marrow of young healthy adult ...
More about LGVN
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email